Newer non-nucleoside transcriptase inhibitor (NNRTI, or non-nuke)–based antiretroviral (ARV) regimens may keep HIV viral loads suppressed when adherence levels are as low as 85 percent, aidsmap reports. Publishing their findings in the Journal of Acquired Immune Deficiency Syndromes, researchers from the U.S. Veteran Aging Cohort Study looked at adherence and viral suppression rates among 22,000 HIV-positive veterans between 2000 and 2010.